X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (187) 187
humans (160) 160
pharmacology & pharmacy (152) 152
medicine & public health (69) 69
pharmacology/toxicology (69) 69
pharmacokinetics (68) 68
pharmacotherapy (66) 66
internal medicine (64) 64
male (59) 59
pharmacokinetic-pharmacodynamic relationship (58) 58
pharmacokinetic-pharmacodynamic-relationships (58) 58
animals (55) 55
female (46) 46
models, biological (45) 45
adult (41) 41
dose-response relationship, drug (40) 40
pharmacokinetic pharmacodynamic relationships (36) 36
middle aged (34) 34
area under curve (32) 32
reviews-on-treatment (29) 29
mycophenolic acid - analogs & derivatives (27) 27
mycophenolic acid - pharmacokinetics (25) 25
toxicology (25) 25
clinical-pharmacokinetics (24) 24
mycophenolic acid - therapeutic use (24) 24
pharmacodynamics (24) 24
pharmacokinetic-pharmacodynamic relationships (24) 24
time factors (24) 24
acute rejection (23) 23
drug interactions (23) 23
transplantation (23) 23
immunosuppressive agents - therapeutic use (22) 22
pharmacology (22) 22
immunosuppressive agents - pharmacokinetics (21) 21
mycophenolate mofetil (21) 21
population pharmacokinetics (21) 21
aged (20) 20
kidney-transplantation (20) 20
therapeutic drug monitoring (19) 19
research (18) 18
treatment outcome (18) 18
analysis (17) 17
drug therapy (17) 17
child (16) 16
clinical pharmacokinetics (16) 16
clinical trials as topic (16) 16
drug monitoring (16) 16
mycophenolic acid (16) 16
pharmacokinetic/pharmacodynamic relationship (16) 16
drug monitoring - methods (15) 15
rats (15) 15
adolescent (14) 14
drugs (14) 14
metabolism (14) 14
mofetil (14) 14
surgery (14) 14
tacrolimus (14) 14
anti-bacterial agents - pharmacokinetics (13) 13
mycophenolic acid - administration & dosage (13) 13
under-the-curve (13) 13
children (12) 12
drug administration schedule (12) 12
in-vitro (12) 12
kidney transplantation (12) 12
limited sampling strategy (12) 12
medical laboratory technology (12) 12
pharmacokinetic-modelling (12) 12
bioavailability (11) 11
biochemistry & molecular biology (11) 11
cyclosporine (11) 11
drug-interactions (11) 11
healthy-volunteers (11) 11
immunosuppressive agents - administration & dosage (11) 11
neoplasms - drug therapy (11) 11
oncology (11) 11
pediatrics (11) 11
pharmacodynamic-modelling (11) 11
renal-allograft recipients (11) 11
renal-transplant recipients (11) 11
research and development (11) 11
tissue distribution (11) 11
antibacterials, pharmacokinetics (10) 10
biological availability (10) 10
chromatography, high pressure liquid (10) 10
computer simulation (10) 10
half-life (10) 10
kinetics (10) 10
young adult (10) 10
administration, oral (9) 9
age factors (9) 9
algorithms (9) 9
allograft recipients (9) 9
dosage and administration (9) 9
dose-prediction (9) 9
double-blind method (9) 9
drug development (9) 9
drug therapy, combination (9) 9
microbial sensitivity tests (9) 9
mycophenolic acid - adverse effects (9) 9
pharmacy (9) 9
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Pharmacokinetics, ISSN 0312-5963, 10/2011, Volume 50, Issue 10, pp. 675 - 686
Background and Objective: Rivaroxaban is an oral, direct Factor Xa inhibitor, which is at an advanced stage of clinical development for prevention and... 
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | Dose-prediction | Rivaroxaban | Pharmacodynamic-modelling | Atrial-fibrillation | Deep-vein-thrombosis | Population- pharmacokinetics | Factor-Xa-inhibitors | Antithrombotics | Pharmacology | Pharmacokinetic-pharmacodynamic-relationships | Pharmacokinetic-modelling | ENOXAPARIN | IN-VITRO | FACTOR-XA INHIBITOR | BAY-59-7939 | MANAGEMENT | VENOUS THROMBOEMBOLISM | METABOLISM | ARTHROPLASTY | PHARMACOLOGY & PHARMACY | PHARMACODYNAMICS | THROMBOPROPHYLAXIS | Body Weight | Age Factors | Anticoagulants - administration & dosage | Factor Xa Inhibitors | Humans | Middle Aged | Venous Thrombosis - blood | Male | Thiophenes - administration & dosage | Morpholines - blood | Thiophenes - blood | Young Adult | Computer Simulation | Aged, 80 and over | Adult | Female | Acute Disease | Stroke - prevention & control | Venous Thrombosis - drug therapy | Administration, Oral | Atrial Fibrillation - drug therapy | Morpholines - administration & dosage | Morpholines - pharmacology | Thiophenes - pharmacology | Anticoagulants - blood | Atrial Fibrillation - blood | Stroke - blood | Thiophenes - pharmacokinetics | Models, Biological | Anticoagulants - pharmacology | Adolescent | Aged | Anticoagulants - pharmacokinetics | Morpholines - pharmacokinetics | Index Medicus
Journal Article
Clinical Pharmacokinetics, ISSN 0312-5963, 2012, Volume 51, Issue 9, pp. 607 - 617
BACKGROUND AND OBJECTIVESevere neutropenia is the most frequent and important toxicity of 3-weekly paclitaxel and puts patients at substantial risk of... 
paclitaxel | antineoplastics | pharmacokinetic-pharmacodynamic-relationships | lung-cancer | Bayesian-analysis | pharmacology | drug-monitoring | neutropenia | pharmacokinetic-modelling | population-pharmacokinetics | algorithm | Index Medicus
Journal Article
Clinical Pharmacokinetics, ISSN 0312-5963, 2008, Volume 47, Issue 3, pp. 203 - 216
Journal Article
Clinical Pharmacokinetics, ISSN 0312-5963, 10/2011, Volume 50, Issue 10, pp. 627 - 635
Journal Article
Clinical Pharmacokinetics, ISSN 0312-5963, 2011, Volume 50, Issue 1, pp. 65 - 74
Background and Objectives: Exenatide is a glucagon-like peptide-1 receptor agonist, available in an immediate-release (IR), twice-daily formulation, which... 
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | Exenatide, pharmacodynamics | Pharmacokinetic- pharmacodynamic-relationships | Population-pharmacokinetics | Antihyperglycaemics, pharmacokinetics | Glucagon-like-peptide-1-stimulants, pharmacokinetics | Diabetes-mellitus | Exenatide, pharmacokinetics | Antihyperglycaemics, pharmacodynamics | Glucagon-like-peptide-1-stimulants, pharmacodynamics | METFORMIN | GLYCEMIC CONTROL | SULFONYLUREA | LIQUID-CHROMATOGRAPHY | GLUCOSE | PHARMACOLOGY & PHARMACY | SYNTHETIC EXENDIN-4 | TREATED PATIENTS | WEIGHT | TYPE-2 | Humans | Middle Aged | Peptides - pharmacokinetics | Male | Dose-Response Relationship, Drug | Glucagon-Like Peptide 1 - agonists | Injections, Subcutaneous | Glucagon-Like Peptide 1 - pharmacokinetics | Hypoglycemic Agents - therapeutic use | Receptors, Glucagon - agonists | Hypoglycemic Agents - pharmacokinetics | Drug Administration Schedule | Glucagon-Like Peptide 1 - pharmacology | Blood Glucose | Hypoglycemic Agents - pharmacology | Peptides - pharmacology | Diabetes Mellitus, Type 2 - blood | Glucagon-Like Peptide-1 Receptor | Gastric Emptying - drug effects | Venoms - therapeutic use | Venoms - pharmacology | Diabetes Mellitus, Type 2 - drug therapy | Delayed-Action Preparations | Peptides - therapeutic use | Venoms - pharmacokinetics | Type 2 diabetes | Drugs | Physiological aspects | Dosage and administration | Research | Pharmacokinetics | Drug therapy | Index Medicus
Journal Article
Journal Article
Journal of the American Association for Laboratory Animal Science, ISSN 1559-6109, 11/2017, Volume 56, Issue 6, pp. 762 - 767
In this study, we compared the plasma concentrations of meloxicam in pediatric rat pups (ages: 7, 14, 21, and 28 d) with those of young adult rats. Adult rats... 
SINGLE | PROFILE | PAIN | ZOOLOGY | FORMULATIONS | INFLAMMATION | ANTIINFLAMMATORY AGENT | VETERINARY SCIENCES | PHARMACOKINETIC-PHARMACODYNAMIC RELATIONSHIPS | HORSES | MODEL | ARTHRITIS | Index Medicus | Anesthesia | Tmax, time to peak plasma concentration | Cmax, peak plasma concentration | PND, post-natal day
Journal Article
Clinical Drug Investigation, ISSN 1173-2563, 2012, Volume 32, Issue 9, pp. 593 - 601
  Background and Objective: Approximately 75% of postmenopausal women experience vasomotor symptoms (hot flashes). Currently, hormone replacement therapy is... 
controlled-release-drugs | pharmacokinetics | pharmacokinetic- pharmacodynamic-relationships | Gabapentin | vasomotor symptoms | Index Medicus
Journal Article
Journal Article
Journal Article